Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104 Meeting Abstract
| Authors: | Soares, H. P.; Guthrie, K. A.; Ahmad, S. A.; Washington, M. K.; Ramnaraign, B. H.; Raj, N. P.; Seigel, C.; Bellasea, S.; Chiorean, E. G.; Dasari, A.; Strosberg, J. R.; Eng, C.; Philip, P. A. |
| Abstract Title: | Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104 |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900500 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.TPS515 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS515 -- Meeting was conducted online as well as in person -- Source: Wos |
